Show simple item record

dc.contributor.authorVelásquez-Hernández, Miriam de J.
dc.contributor.authorLinares-Moreau, Mercedes
dc.contributor.authorAstria, Efwita
dc.contributor.authorCarraro, Francesco
dc.contributor.authorAlyami, Mram Z.
dc.contributor.authorKhashab, Niveen M.
dc.contributor.authorSumby, Christopher J.
dc.contributor.authorDoonan, Christian J.
dc.contributor.authorFalcaro, Paolo
dc.date.accessioned2020-12-27T11:20:49Z
dc.date.available2020-12-27T11:20:49Z
dc.date.issued2020-12
dc.date.submitted2020-07-12
dc.identifier.citationVelásquez-Hernández, M. de J., Linares-Moreau, M., Astria, E., Carraro, F., Alyami, M. Z., Khashab, N. M., … Falcaro, P. (2020). Towards applications of bioentities@MOFs in biomedicine. Coordination Chemistry Reviews, 213651. doi:10.1016/j.ccr.2020.213651
dc.identifier.issn0010-8545
dc.identifier.doi10.1016/j.ccr.2020.213651
dc.identifier.urihttp://hdl.handle.net/10754/666669
dc.description.abstractMetal–organic frameworks (MOFs) combined with biomacromolecules, viruses and cells have emerged as novel biocomposites for application to drug delivery, biosensing, biospecimen preservation, and cell and virus manipulation. The integration of biological entities into MOF matrices generates MOF biocomposites with functional characteristics that cannot be observed in the separate components, such as enhanced chemical and thermal stability, resistance to proteases, MOF-conferred selectivity, and controlled release. In this review, we will discuss these functional properties and applications of the biocomposites obtained by the encapsulation of (i) proteins, (ii) carbohydrates, (iii) nucleic acids, and (iv) viruses or cells in a MOF matrix. Finally, we review the post functionalization of MOF-based drug carriers with lipids as a potential route to enhance the dispersion, stability in biological fluids, and blood circulation time of MOF-based drug delivery systems.
dc.description.sponsorshipThe authors acknowledge support from the European Union's Horizon 2020 FETOPEN-1-2016-2017 research, LP-03, the innovation program under grant agreement 801464, and the European Research Council under the European Union's Horizon 2020 Programme (FP/2014-2020)/ERC Grant Agreement no. 771834 – POPCRYSTAL. M.J.V.H. acknowledges The National Council of Science and Technology (CONACyT, México) for the postdoctoral scholarship (CVU 419210). E.A. acknowledges Austrian Agency for International Cooperation in Education and Research (OeAD-GmbH) for the Ph.D. scholarship. C.J.S. and C.J.D. acknowledge the Australian Research Council (DP170103531 and DP200102411).
dc.publisherElsevier BV
dc.relation.urlhttps://linkinghub.elsevier.com/retrieve/pii/S0010854520306469
dc.rightsThis is an open access article under the CC BY license.
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleTowards applications of bioentities@MOFs in biomedicine
dc.typeArticle
dc.contributor.departmentChemical Science Program
dc.contributor.departmentPhysical Science and Engineering (PSE) Division
dc.contributor.departmentAdvanced Membranes and Porous Materials Research Center
dc.identifier.journalCoordination Chemistry Reviews
dc.eprint.versionPublisher's Version/PDF
dc.contributor.institutionInstitute of Physical and Theoretical Chemistry, Graz University of Technology, Stremayrgasse 9, Graz 8010, Austria
dc.contributor.institutionDepartment of Chemistry and the Centre of Advanced Nanomaterials, University of Adelaide, South Australia 5005, Australia
dc.identifier.pages213651
kaust.personAlyami, Mram Zaid Ali
kaust.personKhashab, Niveen M.
dc.date.accepted2020-10-09
dc.identifier.eid2-s2.0-85097908626
refterms.dateFOA2020-12-27T11:21:57Z


Files in this item

Thumbnail
Name:
Towards application.pdf
Size:
11.70Mb
Format:
PDF
Description:
published version

This item appears in the following Collection(s)

Show simple item record

This is an open access article under the CC BY license.
Except where otherwise noted, this item's license is described as This is an open access article under the CC BY license.